Esperanza Feijoó

807 total citations
19 papers, 653 citations indexed

About

Esperanza Feijoó is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Esperanza Feijoó has authored 19 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Esperanza Feijoó's work include Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (5 papers). Esperanza Feijoó is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (5 papers). Esperanza Feijoó collaborates with scholars based in Spain, United States and Italy. Esperanza Feijoó's co-authors include Ignacio Melero, Carlos Alfaro, Jesús Prìeto, Ainhoa Arina, Guillermo Mazzolini, Iñigo Tirapu, Javier Dotor, Cheng Qian, Juan Ruiz and Bruno Sangro and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Esperanza Feijoó

19 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esperanza Feijoó Spain 12 363 289 214 78 63 19 653
Adel Samson United Kingdom 12 135 0.4× 244 0.8× 155 0.7× 164 2.1× 43 0.7× 30 422
Katsuyoshi Furumoto Japan 11 414 1.1× 290 1.0× 267 1.2× 69 0.9× 52 0.8× 24 755
Chun‐Jen J. Chen New Zealand 11 936 2.6× 283 1.0× 256 1.2× 22 0.3× 75 1.2× 15 1.1k
Chung-Ching Chu United Kingdom 7 844 2.3× 168 0.6× 221 1.0× 62 0.8× 44 0.7× 11 1.0k
Suzanne van Duikeren Netherlands 17 851 2.3× 559 1.9× 327 1.5× 65 0.8× 108 1.7× 25 1.1k
Renee Wu United States 9 726 2.0× 383 1.3× 194 0.9× 67 0.9× 43 0.7× 13 930
Annemiek de Boer Netherlands 8 405 1.1× 371 1.3× 165 0.8× 27 0.3× 20 0.3× 9 615
Giovanni Nitti United States 7 352 1.0× 267 0.9× 296 1.4× 20 0.3× 66 1.0× 9 603
Elisabetta Dondi France 15 348 1.0× 256 0.9× 218 1.0× 73 0.9× 72 1.1× 34 723
Yannick Willemen Belgium 14 671 1.8× 439 1.5× 250 1.2× 36 0.5× 52 0.8× 29 945

Countries citing papers authored by Esperanza Feijoó

Since Specialization
Citations

This map shows the geographic impact of Esperanza Feijoó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esperanza Feijoó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esperanza Feijoó more than expected).

Fields of papers citing papers by Esperanza Feijoó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esperanza Feijoó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esperanza Feijoó. The network helps show where Esperanza Feijoó may publish in the future.

Co-authorship network of co-authors of Esperanza Feijoó

This figure shows the co-authorship network connecting the top 25 collaborators of Esperanza Feijoó. A scholar is included among the top collaborators of Esperanza Feijoó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esperanza Feijoó. Esperanza Feijoó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Blanco‐Prieto, María J., et al.. (2015). Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity. International Journal of Nanomedicine. 10. 6541–6541. 28 indexed citations
2.
Margheri, Francesca, Nicola Schiavone, Laura Papucci, et al.. (2012). GDF5 Regulates TGFß-Dependent Angiogenesis in Breast Carcinoma MCF-7 Cells: In Vitro and In Vivo Control by Anti-TGFß Peptides. PLoS ONE. 7(11). e50342–e50342. 28 indexed citations
3.
4.
Alfaro, Carlos, Natalia Suárez, Iván Martínez‐Forero, et al.. (2011). Carcinoma-Derived Interleukin-8 Disorients Dendritic Cell Migration Without Impairing T-Cell Stimulation. PLoS ONE. 6(3). e17922–e17922. 34 indexed citations
5.
Díaz‐Valdés, Nancy, Javier Dotor, Fernando Aranda, et al.. (2010). Induction of Monocyte Chemoattractant Protein-1 and Interleukin-10 by TGFβ1 in Melanoma Enhances Tumor Infiltration and Immunosuppression. Cancer Research. 71(3). 812–821. 55 indexed citations
6.
Dotor, Javier, Juan José Lasarte, Pablo Sarobe, et al.. (2007). Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library. Cytokine. 39(2). 106–115. 67 indexed citations
7.
Mazzolini, Guillermo, Carlos Alfaro, Bruno Sangro, et al.. (2005). 1134. Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients with Metastatic Gastrointestinal Carcinomas. Molecular Therapy. 11. S437–S438. 5 indexed citations
8.
Feijoó, Esperanza, Carlos Alfaro, Guillermo Mazzolini, et al.. (2005). Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8. International Journal of Cancer. 116(2). 275–281. 90 indexed citations
9.
Tirapu, Iñigo, Ainhoa Arina, Guillermo Mazzolini, et al.. (2004). Improving efficacy of interleukin‐12‐transfected dendritic cells injected into murine colon cancer with anti‐CD137 monoclonal antibodies and alloantigens. International Journal of Cancer. 110(1). 51–60. 61 indexed citations
10.
Mazzolini, Guillermo, Carlos Alfaro, Bruno Sangro, et al.. (2004). Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients With Metastatic Gastrointestinal Carcinomas. Journal of Clinical Oncology. 23(5). 999–1010. 137 indexed citations
11.
Melero, Ignacio, Iñigo Tirapu, Ainhoa Arina, et al.. (2003). Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell death.. PubMed. 9(10 Pt 1). 3546–54. 7 indexed citations
12.
Sarobe, Pablo, Esperanza Feijoó, Carlos Alfaro, Guillermo Mazzolini, & Ignacio Melero. (2003). MAGE antigens: therapeutic targets in hepatocellular carcinoma?. Journal of Hepatology. 40(1). 155–158. 2 indexed citations
13.
Arina, Ainhoa, Iñigo Tirapu, Carlos Alfaro, et al.. (2002). Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. Experimental Hematology. 30(12). 1355–1364. 33 indexed citations
14.
Ramos‐Arroyo, María A., et al.. (2001). Heat-shock protein 70-1 and HLA class II gene polymorphisms associated with celiac disease susceptibility in Navarra (Spain). Human Immunology. 62(8). 821–825. 19 indexed citations
15.
García, Rocío, et al.. (1996). Immune complexes from HIV-1+ patients contain infectious virus able to infect normal lymphocytes. Journal of Allergy and Clinical Immunology. 98(4). 827–830. 5 indexed citations
16.
Feijoó, Esperanza, et al.. (1995). Anti-CD4 Activity in Circulating Immune Complexes in HIV-lnfected Patients. International Archives of Allergy and Immunology. 106(4). 366–371. 4 indexed citations
17.
Feijoó, Esperanza, Fernando López Ortiz, Mercedes Robledo, et al.. (1994). DNA Content in Non-Hodgkin's Lymphoma: Comparison between flow cytometry and cytogenetics in fresh and paraffin-embedded tissue. Acta Oncologica. 33(6). 621–625. 1 indexed citations
18.
Ruíz-Moreno, M, Rosa García, Beatriz Calle Serrano, et al.. (1993). Levamisole and interferon in children with chronic hepatitis B. Hepatology. 18(2). 264–269. 30 indexed citations
19.
Hernando, L, et al.. (1992). Usefulness of serum interleukin 2 receptor levels in renal allograft recipients.. PubMed. 24(1). 63–4. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adel Samson Breakdown of academic impact, for papers by Katsuyoshi Furumoto Breakdown of academic impact, for papers by Chun‐Jen J. Chen Breakdown of academic impact, for papers by Chung-Ching Chu Breakdown of academic impact, for papers by Suzanne van Duikeren Breakdown of academic impact, for papers by Renee Wu Breakdown of academic impact, for papers by Annemiek de Boer Breakdown of academic impact, for papers by Giovanni Nitti Breakdown of academic impact, for papers by Elisabetta Dondi Breakdown of academic impact, for papers by Yannick Willemen
Rankless by CCL
2026